| Literature DB >> 25374690 |
Tyson Belz1, Saleh Ihmaid1, Jasim Al-Rawi1, Steve Petrovski1.
Abstract
NewEntities:
Year: 2013 PMID: 25374690 PMCID: PMC4207449 DOI: 10.1155/2013/436397
Source DB: PubMed Journal: Int J Med Chem ISSN: 2090-2077
Scheme 1Previous synthesis of urea or thiourea 3 (X=O or S) and 2-amino benzo1,3-oxazine 5.
Scheme 2Synthesis of 7-N-substituted-1,3-oxazines 10-11 starting from 2-hydroxy-substituted benzoic acids 8 and 9. Reaction conditions: (i) compound a (Ac)2O, b PhCH=O, c 2-hydroxy-C6H4-CH=O, and d 3-ethoxy-2-hydroxy-C6H3-CH=O, (ii) Ph3P(SCN)2 in CH2Cl2, (iii) NaBH4, and (iv) Ph3P(SCN)2 in CH2Cl2.
Scheme 3Synthesis of N-(benzyl carbamothioyl)-2-hydroxy-substituted benzamide 13, substituted 2-benzylamino-1,3-benzoxazines 15.
Scheme 4Synthesis of substituted-N,N-bis(benzyl carbamothioyl)-dihydroxy-iso and tetra phthalamides 20a, c, and 21. Reaction conditions: (i) Ph3P(SCN)2 in CH2Cl2 and (ii) NaHCO3, PhCH2NH2.
Scheme 5Synthesis of 2-dione-1,3-benzoxazines 22a–I and 25a,b from the 2-methylthio-1,3-benzoxazines 14a,b, d–g, and 24a-b.
Broth dilution susceptibility MIC values for inhibition growth of bacteria (μgmL−1).
| Bacteria | ||||||||
|---|---|---|---|---|---|---|---|---|
| # |
|
|
|
|
|
|
|
|
|
| 200 | 200 | >200 | 200 | 200 | n/a | >200 | 50 |
|
| 200 | 100 | 25 | 200 | 200 | n/a | >200 | 25 |
|
| >300 | >300 | >300 | >300 | >300 | >300 | n/a | n/a |
|
| 200 | >300 | >300 | 200 | >300 | 300 | n/a | n/a |
|
| >300 | >300 | 300 | >300 | >300 | >300 | n/a | n/a |
|
| >300 | >300 | >300 | >300 | >300 | >300 | n/a | n/a |
|
| >300 | >300 | >300 | >300 | >300 | 200 | n/a | n/a |
|
| >300 | >300 | 300 | >300 | >300 | >300 | n/a | n/a |
|
| 200 | 200 | 300 | >300 | >300 | >300 | n/a | n/a |
|
| 300 | >300 | 300 | 300 | >300 | 300 | n/a | n/a |
|
| >200 | 12.5 | >200 | >200 | >200 | n/a | >200 | >200 |
|
| >200 | 25 | >200 | >200 | >200 | n/a | >200 | >200 |
|
| >200 | 25 | 200 | >200 | >200 | n/a | 100 | 50 |
|
| 200 | >200 | >200 | 200 | >200 | n/a | >200 | 200 |
Broth dilution susceptibility MFC values for inhibition growth of fungi (μgmL−1).
| Fungi | ||||
|---|---|---|---|---|
| # |
|
|
|
|
|
| 200 | >200 | >200 | >200 |
|
| 200 | >200 | 100 | >200 |
|
| >200 | >200 | >200 | >200 |
|
| >200 | >200 | >200 | >200 |
|
| >200 | >200 | >200 | >200 |
|
| >200 | >200 | 200 | 200 |
Results showing Disc diffusion susceptibility for the synthesised compounds.
| Bacteria | ||||||||
|---|---|---|---|---|---|---|---|---|
| # |
|
|
|
|
|
|
|
|
|
| S (2 mm) | R | R | R | R | n/a | S (2 mm) | R |
|
| S (2 mm) | S (3 mm) | R | R | R | n/a | S (2 mm) | S (2 mm) |
|
| S (2 mm) | S (2 mm) | R | R | R | n/a | S (2 mm) | S (2 mm) |
|
| S (2 mm) | S (4 mm) | R | R | R | n/a | S (2 mm) | S (2 mm) |
|
| R | S (6 mm) | S (5 mm) | R | R | S (5 mm) | n/a | n/a |
|
| R | S (2 mm) | S (5 mm) | S (2 mm) | R | S (5 mm) | n/a | n/a |
|
| R | S (2 mm) | S (5 mm) | S (2 mm) | R | S (5 mm) | n/a | n/a |
|
| R | S (2 mm) | S (5 mm) | S (2 mm) | R | S (5 mm) | n/a | n/a |
|
| R | R | R | R | R | R | n/a | n/a |
|
| R | R | R | R | R | — | R | R |
|
| R | R | R | R | R | n/a | S (2 mm) | R |
|
| R | R | R | R | R | n/a | R | R |
|
| R | S (2 mm) | R | R | R | n/a | R | R |
|
| R | S (2 mm) | R | R | R | n/a | S (3 mm) | S (4 mm) |
|
| R | S (4 mm) | R | R | R | n/a | R | R |
|
| R | R | R | R | R | n/a | S (3 mm) | S (3 mm) |
|
| R | R | R | R | R | n/a | S (2 mm) | R |
|
| R | R | R | R | R | n/a | R | R |
Disc diffusion susceptibility for the synthesised compounds.
| Fungi | ||||
|---|---|---|---|---|
| # |
|
|
|
|
|
| R | R | R | R |
|
| S (2 mm) | S (3 mm) | S (5 mm) | R |
|
| R | R | R | R |
|
| R | R | R | R |
|
| S (2 mm) | R | R | R |
|
| S (2 mm) | S (2 mm) | S (3 mm) | R |
|
| S (2 mm) | S (2 mm) | S (3 mm) | R |
|
| R | R | R | R |
|
| R | R | R | R |
|
| R | R | R | R |
|
| R | R | R | R |
|
| R | R | R | R |